News Alerts

New selection round for Flagship Clusters

CSIRO has called for applications under the fourth round of its Flagship Clusters program, the main element of the Flagship Collaboration Fund.

Flagship Clusters fund collaborations between CSIRO, universities and other publicly-funded research agencies on projects relevant to goals of CSIRO’s Flagships.
Applications for Clusters will be accepted from eligible Australian higher education institutions, Cooperative Research Centres (CRCs) and other Australian publicly funded research agencies.

Flagship Clusters will be funded for about three years at approximately A$1 million per annum from the Flagship Collaboration Fund. Co-investment from partner organisations is expected, at least matching the contribution from the Flagship Collaboration Fund.  Flagship clusters have been accepted for inclusion on the Australian Competitive Grants Register.

An example of an established cluster is CLLAMMecology, which focuses on water management in the Coorong, Lower Lakes and Murray Mouth region. The cluster is a partnership between the Water for a Healthy Country Flagship, the University of Adelaide, Adelaide, South Australia, Flinders University of South Australia, South Australian Research and Development Institute and South Australian Department for Environment and Heritage.

Specifications for Cluster proposals are provided at http://www.csiro.au/org/FlagshipClusterApplications.html

[ top ]

Defence Materials Technology Centre launched

A new Defence Materials Technology Centre (DMTC) has been established under the Australian Government’s Defence Future Capability Technology Centre Program (DFCTC).

The program, announced in the 2007 Defence and Industry Policy Statement, has been modelled on the Cooperative Research Centres (CRC) Program. It is overseen by the Defence Future Capability Technology Centre Committee, chaired by Dr Roger Lough, Chief Defence Scientist of DSTO, and comprising representatives from Defence, the Department of Innovation, Industry, Science and Research (DIISR) and the Cooperative Research Centres Committee.

The DMTC will receive Australian Government funding of $30 million and a further $52 million from the collaborative partners. It will be managed by the Innovation portfolio and headquartered at Swinburne University in Melbourne. A board of directors has been elected, and Dr Mark Hodge has been appointed as Chief Executive Officer with effect from 30 June.

A key aim of the collaboration is to pool the expertise and resources of industry, universities and publicly funded research agencies to develop defence technology that will enhance the capability of the Australian Defence Force.

There are 13 core participants in the Centre, including DSTO, Bluescope Steel, BAE Systems, Thales Australia, GKN Aerospace, Surface Technology Coatings, ANSTO, Wollongong University, Queensland University, the University of Melbourne, RMIT University and Swinburne University of Technology.

The centre has four research programs: air platforms; maritime platforms; armour applications; and propulsion systems.
More information is at http://www.dsto.defence.gov.au/collaboration/5189/page/5286/

[ top ]

Funding for Defence Capability and Technology Demonstrator (CDT) Projects

Funding of $21.5 million has been announced for 12 projects in the latest round of the Australian Government’s Defence Capability and Technology Demonstrator (CDT) Program.

The Capability and Technology Demonstrator (CTD) Program, managed by the Defence Science and Technology Organisation, funds Australian industry to trial new technology. The work informs Defence of the potential performance and technical risks associated with future implementation.

Projects funded include

• Ka Band Satellite On-The-Move Communications Systems (EM solutions),
• Field Portable Supersonic Particle Deposition unit (Rosebank Engineering),
• Elongate Solar Cells for Energy Generation (The Australian National University),
• Special Sonar for Submarines (Sonartech Atlas),
• Adaptive Tuned Mass Damper for Submarine Engines (University of Adelaide),
• Miniaturised GPS Anti-Jam Module (Tenix Systems),
• Low Band Direction Finding Sub-System (Jenkins Engineering Defence Systems),
• Tactical Electronic Warfare Open Architecture RF Subsystem (BAE Systems),
• Rifle Fired High Velocity Grenade Launcher (Intelligent Sensing),
• Low Cost On-Store Telemetry (Tenix Systems),
• Battlefield Integrated Tactical Exploitation of Sensors (Tenix Systems),
• Helicopter Aid for Maritime Operations (Advanced VTOL Technologies).

Details of the successful projects and more information about the CTD Program are at http://www.dsto.defence.gov.au/collaboration/3743/
The next round of the CTD Program is currently open, with proposals due by 18 July.

[ top ]

Funding for farm water use program

A new research project to investigate how changed farming practices can improve water use and productivity, while delivering better environmental outcomes has been awarded Commonwealth funding of $8.6 million.

The Farms, Rivers and Markets Project will develop a ‘how to’ guide for farmers to integrate their farm water needs with broader environmental needs. It will involve farm-scale demonstrations exploring how the latest technology in water measurement and management, combined with better use of water markets, can boost farm profits
and productivity, improve delivery of water to the farm gate, reduce leakage, and improve water use efficiency.

The three-year project will run out of the University of Melbourne’s Dookie research farm and the surrounding Goulburn-Broken River catchment. It will be managed by Uniwater, a joint initiative of the University of Melbourne and Monash University.

Under the project, researchers in engineering, agriculture and economics will work in partnership with farmers and water managers to help choose the best mix of production opportunities according to individual circumstances.

The project will also provide spin-off environmental benefits including improved salinity and water quality management.

[ top ]

Victoria enters stem cell alliance with Californian institute

The Victorian Government has signed an alliance with the California Institute of Regenerative Medicine (CIRM), headed by Alan Trounson, formerly head of the Monash Institute of Reproduction and Development.

Innovation Minister Gavin Jennings said the alliance would help establish strategic, collaborative projects on stem cell research with a particular focus on accelerating treatments of disease.

“By collaborating with the world’s largest stem cell organisation, Victoria will continue to build its leadership position in stem cell research and pioneering new treatments,” Mr Jennings said.

CIRM and Victoria are laying the foundation for a three-year agreement under which they will jointly seek grant applications, evaluate them, and make recommendations for funding research activities. The initial avenue for collaboration will be the CIRM Disease Team grants. These grants will provide an opportunity for researchers in California and Victoria to collaborate, broadening the potential pool of expertise that can be applied toward research in a specific area.

CIRM was established in 2004 with the passage of Proposition 71, the California Stem Cell Research and Cures Act. To date CIRM has approved 168 research and facility grants totalling more than US$530 million.

In other news on stem cell research, Sydney IVF Limited and the Australian Stem Cell Centre have received $550,000 from the NSW and Victorian Governments to work on the recent discovery in the US and Japan that stem cell-like cells can be made from skin cells. The program will compare cells generated from skin cells, known as induced pluripotent stem (iPS) cells, with stem cells derived from embryos or from a somatic cell nuclear transfer (SCNT) process using clinically unusable eggs. The scientists hope to develop a routine, repeatable method of making patient-specific stem cells within the nationally approved legislative guidelines.

The NSW Minister for Science and Medical Research Verity Firth also announced that in July this year the NSW Government will commence a new program to provide scholarships for PhD research in the area of induced pluripotent stem cells. The scholarship program will be named in honour of Dr Paul Brock in recognition of his efforts to promote research into serious diseases, in particular motor neurone disease.

The Victorian Government has launched a new education and information website ab out stem cell technology. Known as the Stem Cell Channel – www.stemcellchannel.com.au – the site has been developed by the Australian Stem Cell Channel with the support of the Victorian Government.

[ top ]

Victoria to get bioscience supercomputer

The Victorian Premier, John Brumby, has announced that the Victorian Government will invest $50 million, complemented by funding of $50 million from the University of Melbourne, to establish Australia’s first supercomputer at the university’s Parkville Precinct.

Mr Brumby said the supercomputer would focus on life sciences, utilising supercomputing capacity for applications such as large databases of genetic information and complex models of analysis of human systems. According to the University of Melbourne, it will be the most powerful supercomputer and leading computational biology facility dedicated to life sciences research in the world. It will dramatically expand the state’s capacity in bioinformatics, computational biology and advanced biomedical image analysis.

As part of the initiative, the University of Melbourne will develop a Life Sciences Computation Centre to undertake peak computing operations and share its computational biology expertise with other institutions in the Parkville Precinct. Vice Chancellor, Professor Glub Davis,  said researchers from the Parkville Precinct, Monash University and other Victorian research institutions will have access to the computing facility, encouraging a collaborative approach to medical research. 

The University of Melbourne will release initial expressions of interest for the peak computing facility in 2008, with major installations planned for 2009 and 2011.

[ top ]

Fund created to commercialise Victorian, SA and NZ medical technology

West Australian-based superannuation fund Westscheme has committed $30 million in investment capital for a research commercialisation fund to support collaborative research undertaken at universities in Victoria, New Zealand and South Australia.

The Victorian Government will assist with skills and capabilities for the operation of the fund, which will be based in Melbourne,  and the Governments of New Zealand and South Australia are also contributing.

The fund will support early-stage development of start-up companies that will commercialise cross-disciplinary research in medical technology involving participating universities, the private sector and government. Participating institutions include Monash University, the University of Auckland, the University of Adelaide, Flinders University and the University of South Australia.

[ top ]

Queensland funding for collaborative medical research

The Queensland government has announced a suite of new grants under the Smart State Innovation Project Fund.

These include:

• $808,168 to the University of Queensland to develop novel Magnetic Resonance Imaging (MRI) biomarkers to aid accurate and early diagnosis of Alzheimer’s disease. The University of Queensland is collaborating with the Medical University of South Carolina under a biotechnology agreement between South Carolina and Queensland signed in 2005.
• $ 2 million to the Queensland University of Technology (QUT) as a contribution to a $15.639 million project to establish the Australian-Canada Prostate Cancer Research Alliance. Under the alliance specialists from Vancouver will work with counterparts at the Princess Alexandra Hospital Biomedical Precinct in Brisbane and 28 other partners throughout Australia and Canada.
• $1.25 million for the Head and Neck Cancer Centre of Excellence for Asia Pacific at the Princess Alexandra Hospital for research into head and neck cancers that severely affect people in developing nations. The research project has a total value in excess of $11 million and partners included the Queensland Institute of Medical Research and international organisation Atlantic Philanthropies. It will focus on the diagnosis and treatment of Head and Neck Squamous Cell Carcinoma (HNSCC) and Nasopharyngeal Carcinoma (NPC).
• $650,000 towards a joint research project between the University of Queensland (UQ) and the University of Washington improve the diagnosis of malaria and dengue fever, known as the Molecular Diagnostics Platform with Electronic Readout of Nanobarcodes project. The project, which has a total value of $1.8 million, will be led by Doctor Krassen Dimitrov at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN).

In addition, nearly $3 million has been provided under the Smart State Innovation Building Fund to help buy scientific and analytical equipment for the Molecular and Clinical Pathology Research Laboratory at the Princess Alexandra Hospital in Brisbane.

[ top ]

Announcements

Call for proposals Round Six 2008 - French Australian Science and Technology (FAST) Program

Call for proposals Round Six 2008
French Australian Science and Technology (FAST) Program

Overview
The Australian Government in conjunction with the Government of the Republic of France has established the French-Australian Science & Technology (FAST) Program. The Program is jointly managed by the Department of Innovation, Industry, Science & Research (Innovation) and its French counterparts, the Ministry of Higher Education and Research (MESR) and the Ministry of Foreign and European Affairs (MAEE).

The objective of FAST is to promote and support scientific and technological cooperation between Australian and French researchers from public and private institutions or enterprises.

Support Available
Under the FAST program, Australia will contribute a total of up to $A250,000 per round and France up to 150,000 € per round.

FAST will provide financial assistance, on a competitive basis, for collaborative research projects (including project specific follow-up meetings) between Australian and French researchers. Eligible activities for funding support are international travel and living expenses only. Accordingly, funding does not extend to insurance, salaries or equipment expenses. Individual applications may request funding for up to 2 years.

Under the FAST program Round Six, applications will be considered for research collaboration in the areas of life sciences, environmental sciences, and energy.

Australian beneficiaries:
Support for successful Australian applicants will be provided by the Innovation Department to the coordinating Australian organisation. .

French beneficiaries:
Support for successful French applicants will be provided by MAEE in France, through the agency EGIDE.

How to Apply
Applications must be for funding for collaboration between Australian and French partners. Each partner must submit an application to their respective Government (Innovation Department for the Australian applicants, EGIDE for the French). The Round Six call-for-proposals round will open on:

Monday 7 July and will close on Monday 18 August, 2008.

Australian applicants should refer to the FAST guidelines, available at https://sciencegrants.dest.gov.au/ISL/, before commencing their application.

French applicants should refer to the EGIDE website:
http://www.egide.asso.fr/fr/programmes/pai/appels/fast.jhtml

Information about the FAST program is also available on the Embassy of France website:
http://www.ambafrance-au.org/article.php3?id_article=1851

Information
If you require more information please direct all specific questions by email to:
Australia – Ms Suzanne Milthorpe, email: isl@innovation.gov.au
France – Mr Sebastien Languille email: science@ambafrance-au.org

[ top ]

GlaxoSmithKline Australia Post Graduate Support Grant

Announcing the GlaxoSmithKline Australia Post Graduate Support Grant

Our global quest is to improve the quality of human life by enabling people to do more, feel better and live longer. To achieve our quest, GlaxoSmithKline invests up to $35 million each year in Australian research and development - ranking us in Australia’s top 15 R&D companies.*

Support grants for postgraduate research students

GSK Australia is pleased to offer grant awards of up to $15,000 per annum for two years to PhD or Post Doctorate students in the field of human health.

These awards will provide additional financial support to PhD or Post Doctorate research students who are currently in receipt of a research grant from a non-commercial body.

How to apply

For further information and application forms, please visit www.gsk.com.au/research

Closing date for applications and supporting documentation is 5.00pm (AEST) Friday 25 July 2008.

[ top ]

General Sir John Monash Awards

General Sir John Monash Awards

Make a Difference! BE ONE OF AUSTRALIA’S FUTURE LEADERS

General Sir John Monash Awards
• Up to $150,000 over three years
• Postgraduate study commencing 2009
• Applications close 31 August 2008
More information www.monashawards.org

Award Supporters: Federal Government (DEST), Boeing Corporation, Commonwealth Bank Ltd, General Peter Cosgrove AC MC (Retd) Macquarie Bank, the Pratt Foundation, Tenix, the Westfield Foundation and WorleyParsons Ltd.

“Global challenges demand investment in the knowledge society. We seek further competitive advantage by investing in outstanding leaders for Australia’s knowledge society. We offer to Australia’s future leaders the General Sir John Monash Awards for international postgraduate study in any field, at the world’s best universities.”
General Peter Cosgrove AC MC (Retd)
Chairman

Leaders making a difference to Australia’s Future

www.monashawards.org

[ top ]

Conferences & Events

Victorian Minister for Innovation says InnoFuture 08 encourages innovation in Australia

Globally, over two-thirds of wealth is generated through knowledge and services-based industries. The economies thriving in this environment are ones that think beyond traditional, commoditised goods and services.

Victoria is Australia’s strongest non-resource-based state, leading in innovation investment, with a strong focus on commercialising our cutting-edge R&D, building up our research infrastructure and boosting our knowledge and skills base. However, as we are facing increasing challenges from international competition, the key to a sustainable future for all Victorians and for Australia is to support and encourage innovation across our entire economy.

Innovation is a much broader concept than science and R&D and we will continue to drive Victoria’s future by investing in cultural, creative, technical and intellectual infrastructure, building the kind of environment in which ideas, creativity and innovation flourish. Working together through networks that connect ideas and people is central to building a smart, creative, internationally competitive economy that will deliver more high skilled jobs and secure our long-term quality of life.

That is why we are pleased to sponsor the InnoFuture 08 conference, with its focus on encouraging innovation through collaboration, information sharing and mutual support. 

Gavin Jennings MLC, Victorian Minister for Innovation
 

Innovation 2008: InnoFuture 2008

Building Innovation Capacity for the Global Knowledge Economy

InnoFuture is an important forum for managers and thinkers across entire organisations. It was developed in response to the growing need for practical, accountable tools and answers to aid in fast tracking innovation which now depends on the integration of social, economic and environmental objectives in the global context.

In the era of global competition and commoditisation in all industry sectors, business-model innovation is the sustainable way forward. Innovation is an emerging business discipline and it already provides companies that embraced it with fantastic returns. InnoFuture 2008 will present a holistic way of thinking about innovation. It brings together latest models, systems and strategies to create and manage highly competitive and innovative organisations and people. InnoFuture is an inspirational business event designed to take innovation knowledge to the next level of competitiveness. It is about knowledge transfer for businesses and organisations.

For conference dates, location and cost please see the www.innofuture.com.au. Contact: Roxanne Medel, P: (61 3) 8647 5122 F: (61 3) 8647 5161, E: Roxanne.Medel@team.telstra.com.

More about InnoFuture 2008:

InnoFuture Features:
Global Masters of Innovation
Latest Innovation Models and Tools applied by world’s most innovative companies
Hottest Trends in Sustainable and Strategic Innovation
Innovation DNA analysed
Dedicated network of innovative companies and people

Hot Speakers - Global Masters of Innovation and Thought Leadership:
TOM WUJEC Autodesk, Alias (Canada), Return on Imagination
HUNTER LOVINS Natural Capitalism (USA), Drivers of Change
NATHAN SHEDROFF California College of the Arts (USA), Experience Design
ROB SCHADE Strategyn (USA), What Customers Want
MEHRDAD BAGHAI Alchemy Partners, Granularity of Growth
DR TERRY CUTLER National Innovation Review, Chair
DAVID THODEY Telstra, Technology and Innovation Helix
GIAN TARALLI Johnson & Johnson (Brazil), Energizing Innovative Culture

Welcome and special addresses:
PHIL BURGESS Telstra, Technology and the Innovation Helix
HON GAVIN JENNINGS Minister for Innovation, Victoria (invited)

WHEN: 9 - 10 September 2008
WHERE: The Sebel Albert Park, Melbourne, Australia

Info and registrations: www.innofuture.com.au

ENQUIRIES:
InnoFuture Conference Secretariat - Contact: Roxanne Medel, P: (61 3) 8647 5122 F: (61 3) 8647 5161, E: Roxanne.Medel@team.telstra.com

[ top ]

NSX Business Growth Summit to showcase Innovation, Communications and Technology

The National Stock Exchange of Australia (NSX) will present its inaugural NSX Business Growth Summit in Melbourne next month.

The conference will discuss the range of challenges for the SME sector including early stage investing,succession planning,effective communications management, exit strategies as well as recent corporate governance developments and current thinking on the effective utilisation of the capital markets.

A key development over the past few monts has been the establishment of an Australian specialist exchange for technology companies, the Asia Pacific Technology Exchange (APTEX). This is a joint venture between NSX Ltd and Enterprise Pacific, a non-profit company established as part of the Pacific Technology Corridor Business Plan. It is expected that APTEX will be similar to overseas technology exchanges such as Nasdaq,  with 20 companies listing by the end of 2008.

At the NSX Business Growth Summit, Geoff Mullins, Chairman of Enterprise Pacific, will present a session on how APTEX will assist emerging ICT companies in attracting capital, while Professor Roy Green, Dean of Macquarie Graduate School of Management, will speak on the Irish ICT experience. Two ICT case studies will be presented by Jeff Martin, Director Trackaxle and Richard Green, Non Executive Director VentureAxess Fund Managers Ltd.

In another session at the Summit, serial entrepreneurs Rick McElhinney and Jordan Green, will facilitate a workshop which will showcase four early-stage companies and discuss the risks/returns of early stage investing. Rick has invested in and provided advisory services to a number of manufacturing and IT corporations. He has been involved in establishing and currently chairs Founders Forum Limited. The Founders Forum is a network of business angels who syndicate their efforts in assisting start-up companies through investment and mentoring.

Jordan Green is co-founder and Deputy Chairman of the Australian Association of Angel Investors, the national peak body that represents the collective interests of angels and improves the dynamics and success of the Australian angel investment sector. Jordan founded and leads an angel investor group in Melbourne – Victoria’s Investment Partners. In the past 15 years Jordan has been active as an angel and venture investor on three continents and continues to pursue his interests in Australia and overseas as board member and board adviser to a number of private and unlisted public companies.

The inaugural NSX Business Growth Summit will be held in Melbourne on 24-25 July. For further information, and a full line-up of speakers and sessions at this important event,  please visit http://www.halledit.com.au/events.php?id=87

[ top ]

Positions Vacant

Postdoctoral Research Fellow (Medicinal and Biomolecular Chemistry)

Postdoctoral Research Fellow (Medicinal and Biomolecular Chemistry)
Faculty of Pharmacy
Reference No. 132663

The Faculty of Pharmacy is expanding its capabilities in Biomolecular Chemistry, and is seeking to appoint two outstanding postdoctoral researchers in studies on molecular mechanism to identify new drug targets in cancer and atherosclerosis.

The Faculty has an established tradition of advanced research and is a leading research centre in drug design and mode of action in Australia. Covering a broad spectrum of pharmaceutical sciences, the faculty undertakes many collaborative research projects with other faculties within the University, but also with national and international research institutes, the pharmaceutical industry and the profession. Within the discipline of Pharmaceutical Chemistry, the Faculty offers postdoctoral training opportunities in a broad spectrum of pharmaceutical and molecular cell biology sciences ranging from the design and synthesis to the identification and mode of action of drugs.

The Faculty wishes to appoint two exceptional postdoctoral Research Fellows. The successful applicants will be working on NHMRC-funded projects related to (1) the regulation of EGFR and Ras signaling in breast cancer or (2) the role of Ras signaling in cholesterol transport. It is intended that the successful applicants will complement an established highly-skilled, multidisciplinary team and will also contribute to innovative research programs.

The successful applicants must hold a PhD in biology, biochemistry, pharmaceutical sciences or a related discipline, with interest in developing a career within Medicinal and Biomolecular Chemistry-orientated sciences. They will also have excellent doctoral research experience including expertise in tissue culture, subcellular fractionations, western blotting, immunofluorescence microscopy and recombinant DNA technology. An early career record of peer-reviewed publications and experience in seeking research funding would be desirable. Applicants are asked to indicate a preference for one of the two projects listed above.

Information about the Faculty of Pharmacy may be obtained from the Faculty’s website: www.pharm.usyd.edu.au

These positions are initially full-time fixed term for 2.5 years, with the possibility of extension subject to availability of ongoing funding and satisfactory completion of a probation period for new appointees. Membership of a University approved superannuation scheme is a condition of employment for new appointees.

Remuneration package: $76,754 - $82,389 (which includes a base salary Level A $64,858 - $69,620 p.a., leave loading and up to 17% employer’s contribution to superannuation).

For more information or to apply online, please visit http://positions.usyd.edu.au and search by reference number 132663. Specific enquiries about the role can be directed to Dr Thomas Grewal, Lecturer, Pharmaceutical Chemistry on (02) 9351 8496 or via email: tgrewal@pharm.usyd.edu.au Enquiries about the recruitment process can be directed to Julie Small on (02) 9036 7870.

Closinging Date: 10 July 2008

[ top ]

Postdoctoral Research Fellow (Chinese Medicinal Products in Diabetes)

Postdoctoral Research Fellow (Chinese Medicinal Products in Diabetes)
Faculty of Pharmacy
Reference No.133052

The Faculty of Pharmacy is undertaking specialised research in the role of Chinese herbal medicines in diabetes. It is seeking to appoint an outstanding postdoctoral researcher in studies on the pharmacological, cell biological and molecular mechanisms of selected Chinese medicine herbs to identify new drug targets and potential multi-component mechanisms in type 2 diabetes. The position is funded through the National Institute of Complementary Medicine (NICM) Collaborative Centre in Traditional Chinese Medicine (TCM).

The Faculty of Pharmacy has an established tradition of advanced herbal medicines research in Australia. The Herbal Medicines Research and Education Centre within the Faculty covers a broad spectrum of pharmacological and cell biological sciences and undertakes collaborative research projects in diabetes with groups within the University, other national and international universities and research institutes, the herbal medicines industry and the profession.

The successful applicant will be working collaboratively on a NICM funded project involving (1) the selection of suitable herbs (2) pharmacological in vitro cell studies and (3) whole animal molecular mechanism of action experiments. It is intended that the successful applicants will work with established highly-skilled, multidisciplinary teams of the Collaborative Centre and will also contribute to innovative research programs.

The successful applicant must hold a PhD in an area of biology or pharmacology or a related discipline, with interest in developing a career within the natural products sector. The applicant will also have excellent doctoral research experience including expertise in tissue culture, in vitro techniques such as Western blotting, flow cytometry, immunofluorescence microscopy and recombinant DNA technology, while experience in whole animal studies is considered valuable. An early career record of peer-reviewed publications would be highly desirable.

Information about the Faculty of Pharmacy and the Herbal Medicines Research and Education Centre may be obtained from the Faculty and University website: www.pharm.usyd.edu.au

The position is initially full-time fixed term for 12 months, with possible extension up to a further 12 months subject to availability of funding and satisfactory completion of a probation period for new appointees. Membership of a University approved superannuation scheme is a condition of employment for new appointees.

Remuneration package: $76,754 - $82,389 (which includes a base salary Level A $64,858 - $69,620 p.a., leave loading and up to 17% employer’s contribution to superannuation).

For more information or to apply online, please visit http://positions.usyd.edu.au and search by reference number 133052. Specific enquiries about the role can be directed to Professor Basil Roufogalis on (02) 9351 2360, or email: basilr@pharm.usyd.edu.au Enquiries about the recruitment process can be directed to Taya Solodin on (02) 9036 6525.

Closing Date: 8 July 2008

[ top ]